Stryker Corporation vs Vanguard High Dividend Yield ETF — how do they compare? Stryker Corporation trades at $277.33 (market cap $106.24B), while Vanguard High Dividend Yield ETF trades at $158.75 (market cap $100.80B). The key difference: Stryker Corporation and Vanguard High Dividend Yield ETF are close in size by market cap, and Stryker Corporation pays a 1.27% dividend while Vanguard High Dividend Yield ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Stryker Corporation for 21 Days and Vanguard High Dividend Yield ETF for 139 Days on average.
| SYK | VYM | |
|---|---|---|
Market Cap | $106.24B | $100.80B |
Volume | 2,982,001 | 908,176 |
Sector | Health | — |
52-Week High | $388.35 | $167.03 |
52-Week Low | $269.75 | $137.47 |
Typical Hold Time | 21 Days | 139 Days |
Enterprise Value | $117.70B | — |
Dividend Yield | 1.27% | — |
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.
Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.
VYM trades at $158.25, up 0.51% today, with a bearish technical signal from moving averages. The ETF maintains consistent dividend distributions, with the next payment scheduled for September 2026. Recent news highlights VYM's position as a reliable dividend ETF, though some analysts suggest alternative portfolios may offer superior returns. The fund's broad diversification across nearly 600 holdings provides stability but faces criticism for including companies with recent dividend cuts.
VYM offers steady income with moderate yield but faces competition from higher-performing dividend ETFs. Key risks include exposure to companies with potential dividend reductions and underperformance relative to peer strategies. The fund's low expense ratio and diversification remain attractive for conservative income investors seeking reliable quarterly payments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →